金沙集团1862cc(股份)有限公司-baidu百科

2025-08-26

Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as...

查看详情

09-152025

Bio-Thera Strikes Strategic Deal with Jamjoom Pharma for Securing Cosentyx® Biosimilar in MENA

Guangzhou, China / Jeddah, Saudi Arabia – September 15,2025 –Bio-Thera Solutions Inc.(688177:SH), a commercial-stage bio...
09-112025

Medicines and Healthcare products Regulatory Agency (MHRA) Approves Bio-Thera Solutions’ Qletli® (adalimumab), a biosimilar referencing Humira®

Guangzhou,China– September 10, 2025 –Bio-TheraSolutions Inc. (688177:SH),a commercial-stage biopharmaceutical company de...
08-262025

The European Commission (EC) Approves Bio-Thera Solutions’ BAT2206 (USYMRO®, ustekinumab), a biosimilar referencing Stelara®

Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as...